Bortetrust 2 Injection
  1. Home
  2. Pharma Products
  3. Panacea Biotec Ltd
  4. Bortetrust 2 Injection

Bortetrust 2 Injection

Bortetrust 2 Injection contains bortezomib 2 mg, a proteasome inhibitor used in cancer treatment. It is used for conditions such as multiple myeloma and mantle-cell lymphoma. The medicine is administered by a qualified healthcare professional under medical supervision.

BUY NOW

Category

Bortetrust 2 Injection is supplied as a lyophilized powder for injection containing 2 mg of bortezomib. Bortezomib works by inhibiting proteasomes, causing the accumulation of proteins within cancer cells and contributing to their death. The product is administered by intravenous or subcutaneous injection according to the prescribed treatment protocol. Dose, treatment schedule, and monitoring are determined by the treating oncology specialist based on the patient’s condition.

Technical Specification

Specification Details
Active Ingredient Bortezomib 2 mg
Dosage Form Lyophilized Powder for Injection
Therapeutic Class Proteasome Inhibitor
Main Indication Multiple Myeloma
Packaging 1 Vial
Storage Below 30°C

Product Also Known As

Bortetrust 2 Injection, Bortetrust 2 mg Injection, Bortezomib 2 mg Injection, Bortezomib Injection, Bortezomib 2 mg Vial, Bortezomib Oncology Injection